ZYBT
NASDAQ · Pharmaceuticals
Zhengye Biotechnology Holdin
$1.43
+0.05 (+3.62%)
Open$1.36
Previous Close$1.38
Day High$1.46
Day Low$1.35
52W High$8.01
52W Low$0.62
Volume—
Avg Volume66.6K
Market Cap41.66M
P/E Ratio—
EPS$-1.93
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 75.27M | 12.11M | 10.68M |
| Net Income | -45,141,301 | 2.69M | 1.92M |
| Profit Margin | -60.0% | 22.3% | 18.0% |
| EBITDA | -28,864,949 | 3.66M | 3.67M |
| Free Cash Flow | — | 1.61M | 1.47M |
| Rev Growth | +664.7% | -0.1% | -5.4% |
| Debt/Equity | 0.30 | 0.37 | 0.43 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |